Determining Current Medications Usage Within a Cohort of Patients in the UK-A Descriptive Retrospective Study

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2022 Dec 23

PMID 36553945

Authors

Adel S Alhlayl

Haitham A Alzghaibi

Qazi Mohammad Sajid Jamal

Affiliations

Soon will be listed here.

Abstract

Swansea University's United Kingdom (UK) Multiple Sclerosis (MS) Register is a platform that contains information on more than 17,600 people with MS living in the UK. The register has been in operation since 2011 and represents comprehensive information about people living with MS in the UK. It is considered the first register of its kind that can link information from patients to clinical data and has been established to answer different information needs about MS. : To elucidate the trends in patterns of medicines currently used by people with MS in the UK MS register. : This study follows an exploratory descriptive design using the UK MS register as data resource. A number of 4516 people completed the EQ-5D survey out of 8736 people who have given their consent to answer online questionnaires which represents around 52% of the register total population. Descriptive analysis and tests were performed with SPSS to address the research objectives. : There are several medicine names entered by people with MS in their profiles. These medicines are used either to manage MS symptoms or to treat its associated complications. Among the medicine types revealed in this study, disease modifying drugs (DMDs), muscle relaxants, and anticonvulsants are the medicine types mainly used by people with MS followed by antidepressant and antianxiety medicines. : From the antidepressants used most widely, amitriptyline was chosen as a subject medicine for further investigation in the remaining studies of this research due to its high frequency use, the elevated depression rates discovered among people with MS who seek information on it online, and the high online content noted on websites about this medicine.

References

Veauthier C, Gaede G, Radbruch H, Sieb J, Wernecke K, Paul F . Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity. Neuropsychiatr Dis Treat. 2015; 11:2323-9. PMC: 4574879. DOI: 10.2147/NDT.S83350. View

Arnett P, Barwick F, Beeney J . Depression in multiple sclerosis: review and theoretical proposal. J Int Neuropsychol Soc. 2008; 14(5):691-724. DOI: 10.1017/S1355617708081174. View

Turner A, Alschuler K . Anxiety is more important than depression in MS - No. Mult Scler. 2018; 24(4):442-444. DOI: 10.1177/1352458517748477. View

Vermani M, Marcus M, Katzman M . Rates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study. Prim Care Companion CNS Disord. 2011; 13(2). PMC: 3184591. DOI: 10.4088/PCC.10m01013. View

Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D . Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. 2021; 373:n972. PMC: 8107836. DOI: 10.1136/bmj.n972. View

Hamidi V, Couto E, Ringerike T, Klemp M . A Multiple Treatment Comparison of Eleven Disease-Modifying Drugs Used for Multiple Sclerosis. J Clin Med Res. 2018; 10(2):88-105. PMC: 5755648. DOI: 10.14740/jocmr3168w. View

Brown R, Valpiani E, Tennant C, Dunn S, Sharrock M, Hodgkinson S . Longitudinal assessment of anxiety, depression, and fatigue in people with multiple sclerosis. Psychol Psychother. 2008; 82(Pt 1):41-56. DOI: 10.1348/147608308X345614. View

Awol S, Birhanu A, Mekonnen Z, Gashu K, Shiferaw A, Endehabtu B . Health Professionals' Readiness and Its Associated Factors to Implement Electronic Medical Record System in Four Selected Primary Hospitals in Ethiopia. Adv Med Educ Pract. 2020; 11:147-154. PMC: 7041609. DOI: 10.2147/AMEP.S233368. View

Silva A, Vilhena E, Lopes A, Santos E, Goncalves M, Pinto C . Depression and anxiety in a Portuguese MS population: associations with physical disability and severity of disease. J Neurol Sci. 2011; 306(1-2):66-70. DOI: 10.1016/j.jns.2011.03.042. View

10.

Solaro C, Gamberini G, Masuccio F . Depression in Multiple Sclerosis: Epidemiology, Aetiology, Diagnosis and Treatment. CNS Drugs. 2018; 32(2):117-133. DOI: 10.1007/s40263-018-0489-5. View

11.

Snaith R . The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003; 1:29. PMC: 183845. DOI: 10.1186/1477-7525-1-29. View

12.

Morgan M, Montagne M . Drugs on the Internet, part II: antidepressant medication web sites. Subst Use Misuse. 2011; 46(13):1628-41. DOI: 10.3109/10826084.2011.588878. View

13.

Stoll S, Nieves C, Tabby D, Schwartzman R . Use of therapies other than disease-modifying agents, including complementary and alternative medicine, by patients with multiple sclerosis: a survey study. J Am Osteopath Assoc. 2012; 112(1):22-8. View

14.

Hanna M, Strober L . Anxiety and depression in Multiple Sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life. Mult Scler Relat Disord. 2020; 44:102261. PMC: 7719086. DOI: 10.1016/j.msard.2020.102261. View

15.

Stern A . The hospital anxiety and depression scale. Occup Med (Lond). 2014; 64(5):393-4. DOI: 10.1093/occmed/kqu024. View

16.

Crawford J, Henry J, Crombie C, TAYLOR E . Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2002; 40(4):429-34. DOI: 10.1348/014466501163904. View

17.

Mohr D, Hart S, Fonareva I, Tasch E . Treatment of depression for patients with multiple sclerosis in neurology clinics. Mult Scler. 2006; 12(2):204-8. DOI: 10.1191/135248506ms1265oa. View

18.

Wang H . MicroRNAs, Multiple Sclerosis, and Depression. Int J Mol Sci. 2021; 22(15). PMC: 8346048. DOI: 10.3390/ijms22157802. View

19.

Boeschoten R, Braamse A, Beekman A, Cuijpers P, van Oppen P, Dekker J . Prevalence of depression and anxiety in Multiple Sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2016; 372:331-341. DOI: 10.1016/j.jns.2016.11.067. View

20.

Lyons R, Jones K, John G, Brooks C, Verplancke J, Ford D . The SAIL databank: linking multiple health and social care datasets. BMC Med Inform Decis Mak. 2009; 9:3. PMC: 2648953. DOI: 10.1186/1472-6947-9-3. View